Bowman-birk inhibitors from legumes and human gastrointestinal health: Current status and perspectives

Current Protein and Peptide Science

Volumn 12, Issue 5, 2011, Pages 358-373

  Clemente, Alfonso ^a   Sonnante, Gabriella ^b   Domoney, Claire ^c  

^a CSIC   (Spain)

^b Institute of Biosciences and Bioresources   (Italy)

^c JOHN INNES CENTRE   (United Kingdom)

Author keywords

Bowman birk inhibitors; Chemoprevention; Colorectal cancer; Legumes; Serine proteases

Indexed keywords

BOWMAN BIRK INHIBITOR; CHYMOTRYPSIN INHIBITOR; SERINE PROTEINASE;

AMINO ACID SEQUENCE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER PREVENTION; CARCINOGENESIS; CHEMOPROPHYLAXIS; COLITIS; COLON CARCINOGENESIS; COLORECTAL CANCER; DRUG POTENCY; DRUG SYNTHESIS; ENZYME INHIBITION; GASTROINTESTINAL TRACT; GENE SEQUENCE; GENETIC MARKER; GENETIC POLYMORPHISM; HEALTH PROMOTION; HUMAN; LEGUME; LENTIL; MOUTH CANCER; MULTIPLE SCLEROSIS; MUSCLE ATROPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; NUTRITION; PEA; PROSTATE CANCER; PROTEIN DEGRADATION; RADIATION PROTECTION; SOYBEAN; STOMACH CARCINOGENESIS; SURVIVAL;

ANIMALS; ANTINEOPLASTIC AGENTS; FABACEAE; FOOD; GASTROINTESTINAL TRACT; HUMANS; NEOPLASMS; RADIATION-PROTECTIVE AGENTS; TRYPSIN INHIBITOR, BOWMAN-BIRK SOYBEAN;

CICER ARIETINUM; GLYCINE MAX; LENS CULINARIS; PISUM SATIVUM;

EID: 79960338571     PISSN: 13892037     EISSN: 18755550     Source Type: Journal    
DOI: 10.2174/138920311796391133     Document Type: Article

References (168)

1. Rubio, L.A.; Pedrosa, M.M.; Cuadrado, C.; Gelencser, E.; Clemente, A.; Burbano, C.; Muzquiz, M. Recovery at the terminal ileum of some legume non-nutritional factors in cannulated pigs. J. Sci. Food Agric., 2006, 86, 979-987.
2. Clemente, A.; Jimenez, E.; Marín-Manzano, M.C.; Rubio, L.A. Active Bowman-Birk inhibitors survive gastrointestinal digestion at the terminal ileum of pigs fed chickpea-based diets. J. Sci. Food Agric., 2008, 88, 523-531.
3. Marín-Manzano, M.C.; Ruiz, R.; Jimenez, E.; Rubio, L.A.; Clemente, A. Anti-carcinogenic soyabean Bowman-Birk inhibitors survive faecal fermentation in their active form and do not affect the microbiota composition in vitro. Br. J. Nutr., 2009, 101, 967-971.
4. Moreno, F.J.; Clemente, A. 2S albumin storage proteins: what makes them food allergens? Open Biochem. J., 2008, 2, 11-23.
5. Pusztai, A.; Bardocz, S.; Martin-Cabrejas, M.A. In: Recent advances of research in antinutritional factors in legume seeds and oilseeds, Proceedings of the 4th international workshop on antinutritional factors in legume seed and oilseeds, Toledo, Spain, March 8-10, 2004; Muzquiz, M.; Hill, G.D.; Cuadrado, C.; Pedrosa, M.M.; Burbano, C., Eds. Wageningen Academic Pubs, Wageningen, The Netherlands, 2004; pp. 87-100.
6. Pusztai, A.; Bardocz, S.; Ewen, S.W.B. Uses of plant lectins in bioscience and biomedicine. Front. Biosci. 2008, 13, 1130-1140.
7. Gelencser, E. A novel research strategy for safe use of legume proteins in human nutrition. Acta Aliment., 2009, 38, 61-70.
8. Kennedy, A.R. Chemopreventive agents: Protease inhibitors. Pharmacol. Ther., 1998, 78, 167-209.
9. Clemente, A.; Domoney, C. Biological significance of polymorphism in legume protease inhibitors from the Bowman-Birk family. Curr. Prot. Pept. Sci., 2006, 7, 201-216.
10. Kennedy, A.R.; Szuhaj, B.F.; Newberne, P.M.; Billings, P.C. Preparation and production of a cancer chemopreventive agent, Bowman-Birk inhibitor concentrate. Nutr. Cancer, 1993, 19, 281-302.
11. Malkowicz, S.B.; McKenna, W.G.; Vaughn, D.J.; Wan, X.S.; Propert, K.J.; Rockwell, K.; Marks, S.H.F.; Wein, A.J.; Kennedy, A.R. Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia. Prostate, 2001, 48, 16-28.
12. Armstrong, W.B.; Kennedy, A.R.; Wan X.S.; Atiba, J.; McLaren, C.E.; Meyskens, F.L. Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia. Cancer Epidemiol. Biomarkers Prev., 2000, 9, 43-47.
13. Armstrong W.B.; Kennedy, A.R.; Wan, X.S.; Taylor, T.H.; Nguyen, Q.A.; Jensen, J.; Thompson, W. Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial. Clin. Cancer Res., 2000, 6, 4684-4691.
14. Lichtenstein, G.R.; Deren, J.; Katz, S.; Lewis, J.D.; Kennedy A.R.; Ware, J.H. Bowman-Birk inhibitor concentrate: A novel therapeutic agent for patients with active ulcerative colitis. Dig. Dis. Sci., 2008, 53, 175-180.
15. Laskowski, M.Jr.; Kato, I. Protein inhibitors and proteinases. Annu. Rev. Biochem. Sci., 1980, 14, 268-271.
16. Ryan, C.A. Protease inhibitors in plants. Genes for improving defenses against insects and pathogens. Annu. Rev. Phytopathol., 1990, 28, 425-449.
17. Luckett, S.; Garcia, R.S.; Barker, J.J.; Konarev, A.V.; Shewry, P.R.; Clarke, A.R; Brady, R.L. High-resolution structure of a potent, cyclic proteinase inhibitor from sunflower seeds. J. Mol. Biol., 1999, 290, 525-533.
18. Birk, Y. The Bowman-Birk inhibitor - trypsin inhibitor and chymotrypsin inhibitor from soybeans. Int. J. Pept. Protein Res., 1985, 25, 113-131.
19. Tan, C.G.L.; Stevens, F.C. Amino acid sequence of lima bean protease inhibitor component-IV. 2. Isolation and sequence determination of chymotryptic peptides and complete amino acid sequence. Eur. J. Biochem., 1971, 18, 515-523.
20. Odani, S.; Koide, T.; Ono, T. Wheat trypsin inhibitors. Isolation and structural characterization of single-headed and double-headed inhibitors of the Bowman-Birk type. J. Biochem., 1986, 100, 975-983.
21. Prakash, B.; Selvaraj, S.; Murthy, M.R.N.; Sreerama, Y.N.; Rao, D.R.; Gowda, L.R. Analysis of the amino acid sequences of plant Bowman-Birk inhibitors. J. Mol. Evol., 1996, 42, 560-569.
22. Qu, L.J.; Chen, J.; Liu, M.H.; Okamoto, H.; Lin, Z.Z.; Li, C.Y.; Wang, J.L.; Zhu, G.F.; Zhao, X.; Chen, X.; Gu, H.G.; Chen, Z.L. Molecular cloning and functional analysis of a novel type of Bowman-Birk inhibitor gene family in rice. Plant Physiol., 2003, 133, 560-570.
23. Mello, M.O.; Tanaka, A.S.; Silva-Filho, M.C. Molecular evolution of Bowman-Birk type proteinase inhibitors in flowering plants. Phylogenet. Evol., 2003, 27, 103-112.
24. Bode, W.; Huber, R. Natural protein proteinase-inhibitors and their interaction with proteinases. Eur. J. Biochem., 1992, 204, 433-451.
25. Chen, P.; Rose, J.; Love, R.; Wei, C.H.; Wang, B.C. Reactive sites of an anticarcinogenic Bowman-Birk proteinase inhibitor are similar to other trypsin inhibitors. J. Biol. Chem., 1992, 267, 1990-1994.
26. Lin, G.; Bode, W.; Huber, R.; Chi, C.; Engh, R.A. The 0.25 nm Xray structure of the Bowman-Birk type inhibitor from mung bean in ternary complex with porcine trypsin. Eur. J. Biochem., 1993, 212, 549-555.
27. Piergiovanni, A.R.; Galasso, I. Polymorphism of trypsin and chymotrypsin binding loops in Bowman-Birk inhibitors from common bean (Phaseolus vulgaris L.). Plant Sci., 2004, 166, 1525-1531.
28. Perona, J.J.; Craik, C.S. Structural basis of substrate-specificity in the serine proteases. Protein Sci., 1995, 4, 337-360.
29. Gariani, T.; McBride, J.D.; Leatherbarrow, R.J. The role of the P-2' position of Bowman-Birk proteinase inhibitor in the inhibition of trypsin. Studies on P-2' variation in cyclic peptides encompassing the reactive site loop. Biochim. Biophys. Acta, 1999, 1431, 232-237.
30. Gariani, T.; Leatherbarrow, R.J. Stability of protease inhibitors based on the Bowman-Birk reactive site loop to hydrolysis by proteases. J. Peptide Res., 1997, 49, 467-475.
31. Brauer, A.B.E.; Leatherbarrow, R.J. The conserved P1' Ser of Bowman-Birk-type proteinase inhibitors is not essential for the integrity of the reactive site loop. Biochem. Biophys. Res. Commun., 2003, 308, 300-305.
32. Brauer, A.B.E.; Kelly, G.; Matthews, S.J.; Leatherbarrow, R.J. The H-1-NMR solution structure of the antitryptic core peptide of Bowman-Birk inhibitor proteins: A minimal 'canonical loop'. J. Biomol. Struct. Dyn., 2002, 20, 59-70.
33. Domoney, C.; Welham, T.; Sidebottom, C.; Firmin, J.L. Multiple isoforms of Pisum trypsin inhibitors result from modification of two primary gene products. FEBS Lett., 1995, 360, 15-20.
34. Deshimaru, M.; Yoshimi, S.; Shioi, S.; Terada, S. Multigene family for Bowman-Birk type proteinase inhibitors of wild soja and soybean: the presence of two BBI-A genes and pseudogenes. Biosci. Biotechnol. Biochem., 2004, 68, 1279-1286.
35. Sonnante, G.; De Paolis, A.; Pignone, D. Bowman-Birk inhibitors in Lens: identification and characterization of two paralogous gene classes in cultivated lentil and wild relatives. Theor. Appl. Genet., 2005, 110, 596-604.
36. Galasso, I.; Piergiovanni, A.R.; Lioi, L.; Campion, B.; Bollini, R.; Sparvoli, F. Genome organization of Bowman-Birk inhibitor in common bean (Phaseolus vulgaris L.). Mol. Breeding, 2009, 23, 617-624.
37. Ragg, E.M.; Galbusera, V.; Scarafoni, A.; Negri, A.; Tedeschi, G.; Consoni, A.; Sessa, F.; Duranti, M. Inhibitory properties and solution structure of a potent Bowman-Birk protease inhibitor from lentil (Lens culinaris, L.) seeds. FEBS J., 2006, 273, 4024-4039.
38. Domoney, C.; Welham, T.; Ellis, N.; Mozzanega, P.; Turner, L. Three classes of proteinase inhibitor gene have distinct but overlapping patterns of expression in Pisum sativum plants. Plant Mol. Biol., 2002, 48, 319-329.
39. Weder, J.K.P.; Hinkers, S.C. Complete amino acid sequence of the lentil trypsin-chymotrypsin inhibitor LCI-1.7 and a discussion of atypical binding sites of Bowman-Birk inhibitors. J. Agric. Food Chem., 2004, 52, 4219-4226.
40. Caccialupi, P; Ceci, L.R.; Siciliano, R.A.; Pignone, D.; Clemente, A., Sonnante, G. Bowman-Birk inhibitors in lentil: heterologous expression, functional characterisation and anti-proliferative properties in human colon cancer cells. Food Chem., 2010, 120, 1058-1066.
41. Brenes, A.; Jansman, A.J.M.; Marquardt, R.R. Recent progress on research on the effects of antinutritional factors in legume and oil seeds in monogastric animals. In: Recent advances of research in antinutritional factors in legume seeds and oilseeds, Proceedings of the 4th international workshop on antinutritional factors in legume seed and oilseeds, Toledo, Spain, March 8-10, 2004; Muzquiz, M.; Hill, G.D.; Cuadrado, C.; Pedrosa, M.M.; Burbano, C., Eds. Wageningen Academic Pubs, Wageningen, The Netherlands, 2004; pp. 195-217.
42. Jezierny, D.; Mosenthin, R.; Bauer, E. The use of grain legumes as a protein source in pig nutrition: A review. Anim. Feed Sci. Tech., 2010, 157, 111-128.
43. Lajolo, F.M.; Genovese, M.I.; Pryme, I.F.; Dale, T.M. Beneficial (antiproliferative) effects of different substances. In: Recent advances of research in antinutritional factors in legume seeds and oilseeds, Proceedings of the 4th international workshop on antinutritional factors in legume seed and oilseeds, Toledo, Spain, March 8-10, 2004; Muzquiz, M.; Hill, G.D.; Cuadrado, C.; Pedrosa, M.M.; Burbano, C., Eds. Wageningen Academic Pubs, Wageningen, The Netherlands, 2004; pp. 123-135.
44. Clarke, E.; Wiseman, J. Effects of variability in trypsin inhibitor content of soya bean meals on true and apparent ileal digestibility of amino acids and pancreas size in broiler chicks. Anim. Feed Sci. Technol., 2005, 121, 125-138.
45. Muel, F.; Carrouee, B; Grosjean, F. Trypsin inhibitor activity in pea cultivars: new data and a proposal strategy for breeding programmes. In: Proceedings of the Third European Conference on Grain Legumes, Valladolid, Spain, November, 14-19, 1998; AEP (Association Européenne de recherche sur les Protéagineux), Ed. Paris, France, 1998; pp. 164-165.
46. Domoney, C.; Welham, T.; Ellis, N.; Hellens, R. Inheritance of qualitative and quantitative trypsin inhibitor variants in Pisum. Theor. Appl. Genet., 1994, 89, 387-391.
47. Page, D.; Aubert, G.; Duc, G.; Welham, T.; Domoney, C. Combinatorial variation in coding and promoter sequences of genes at the Tri locus in Pisum sativum accounts for variation in trypsin inhibitor activity in seeds. Mol. Gen. Genomics, 2002, 267, 359-369.
48. Kaló, P.; Seres, A.; Taylor, S.A.; Jakab, J.; Kevei, Z.; Kereszt, A.; Endre, G.; Ellis, T.H.N.; Kiss, G.B. Comparative mapping between Medicago sativa and Pisum sativum. Mol. Gen. Genomics, 2004, 272, 235-246.
49. Hedemann, M.S.; Welham, T.; Boisen, S.; Canibe, N.; Bilham, L.; Domoney, C. Studies on the biological responses of rats to seed trypsin inhibitors using near-isogenic lines of Pisum sativum L. (pea). J. Sci. Food Agric., 1999, 79, 1647-1653.
50. Wiseman, J.; Al-Mazooqi, W.; Welham, T.; Domoney, C. The apparent ileal digestibility, determined with young broilers, of amino acids in near-isogenic lines of peas (Pisum sativum L.) differing in trypsin inhibitor activity. J. Sci. Food Agric., 2003, 83, 644-651.
51. Wiseman, J.; Al-Marzooqi, W.; Hedley, C.; Wang, T.L.; Welham, T.; Domoney, C. The effects of genetic variation at r, rb and Tri loci in Pisum sativum L. on apparent ileal digestibility of amino acids in young broilers. J. Sci. Food Agric., 2006, 86, 436-444.
52. Ellis, T.H.N.; Domoney, C.; Castleton, J.; Cleary, W.; Davies, D.R. Vicilin genes of Pisum. Mol. Gen. Genet., 1986, 205, 164-169.
53. Zhukov, V.A.; Kuznetsova, E.V.; Ovchinnikova, E.S.; Rychagova, T.S.; Titov, V.S.; Pinaev, A.G.; Borisov, A.Y.; Moffet, M.; Domoney, C.; Ellis, T.H.N.; Ratet, P.; Weeden, N.F.; Tikhonovich, I.A. Gene-based markers of pea linkage group V for mapping genes related to symbioses. Pisum Genet., 2007, 39, 19-25.
54. Livingstone, D.; Beilinson, V.; Kalyaeva, M.; Schmidt, M.A.; Herman, E.M.; Nielsen, N.C. Reduction of protease inhibitor activity by expression of a mutant Bowman-Birk gene in soybean seed. Plant Mol. Biol., 2007, 64, 397-408.
55. Clemente, A.; Domoney, C. Therapeutic properties of legume protease inhibitors from the Bowman-Birk family. In: Recent Progress in Medicinal Plants; Govil, J.N., Singh, V.K., Sharma, R.K., Eds.; SCI Tech Publishing LLC, Houston, USA. 2007; Vol 20, pp. 397-417.
56. Osman, M.A.; Reid, P.M.; Weber, C.W. Thermal inactivation of tepary bean (Phaseolus acutifolius), soybean and lima bean protease inhibitors: effect of acidic and basic pH. Food Chem., 2002, 78, 419-423.
57. Yavelow, J.; Finlay, T.H.; Kennedy, A.R.; Troll, W. Bowman-Birk soybean protease inhibitor as an anticarcinogen. Cancer Res., 1983, 43, 2454-2459.
58. Park, J.H.; Jeong, H.J.; Lumen, B.O.D. In vitro digestibility of the cancer-preventive soy peptides lunasin and BBI. J. Agric. Food Chem., 2007, 55, 10703-10706.
59. Weder, J.K. Inhibition of human proteinases by grain legumes. Adv. Exp. Med. Biol., 1986, 199, 239-279.
60. Hajos, G.; Gelencser, E.; Pusztai, A.; Grant, G.; Sakhri, M.; Bardocz, S. Biological effects and survival of trypsin inhibitors and the agglutinin from soybean in the small intestine of the rat. J. Agric. Food Chem., 1995, 43, 165-170.
61. Pusztai, A.; Grant, G.; Brown, D.J.; Stewart, J.C.; Bardocz, S.; Ewen, S.W.B.; Gatehouse, A.M.R.; Hilder, V. Nutritional evaluation of the trypsin (E.C. 3.4.21.4) inhibitor from cowpea (Vigna unguiculata). Br. J. Nutr., 1992, 68, 783-391.
62. Billings, P.C.; St. Clair, W.H.; Maki, P.A.; Kennedy, A.R. Distribution of the Bowman-Birk protease inhibitor in mice following oral administration. Cancer Lett., 1992, 62, 191-197.
63. Ramasarma, P.R.; Appu Rao, A.G.; Rao, D.R. Role of disulfide linkages in structure and activity of proteinase inhibitor from horsegram (Dolichos biflorus). Biochim. Biophys. Acta, 1995, 1248, 35-42.
64. Clemente, A.; Vioque, J.; Sanchez-Vioque, R.; Pedroche, J.; Bautista, J.; Millan, F. Factors affecting the in vitro protein digestibility of chickpea albumins. J. Sci. Food Agric., 2000, 80, 79-84.
65. Qi, R.F.; Song, Z.W.; Chi, C.W. Structural features and molecular evolution of Bowman-Birk protease inhibitors and their potential application. Acta Biochim. Biophys. Sin., 2005, 37, 283-292.
66. Trivedi, M.V.; Laurence, J.S.; Siahann, T.J. The role of thiols and disulfides on protein stability. Curr. Prot. Pept. Sci., 2009, 10, 614-625.
67. Philipp, S.; Kim, Y.M.; Dürr, I.; Wenzl, G.; Vogt, M.; Flecker, P. Mutational analysis of disulfide bonds in the trypsin-reactive subdomain of a Bowman-Birk-type inhibitor of trypsin and chymotrypsin. Cooperative versus autonomous refolding of subdomains. Eur. J. Biochem., 1998, 251, 854-862.
68. Clemente, A.; Moreno, J.; Marín-Manzano, M.C.; Jiménez, E.; Domoney, C. The cytotoxic effect of Bowman-Birk isoinhibitors, IBB1 and IBBD2, from soybean (Glycine max) on HT29 human colorectal cancer cells is related to their intrinsic ability to inhibit serine proteases. Mol. Nutr. Food Res., 2010, 54, 396-405.
69. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Thun, M.J. Cancer Statistics, 2009. Cancer J. Clin., 2009, 59, 225-249.
70. Cummings, J.H.; Bingham, S.A. Fortnightly review - Diet and the prevention of cancer. Br. Med. J., 1998, 317, 1636-1640.
71. Reddy, B.S. Novel approaches to the prevention of colon cancer by nutritional manipulation and chemoprevention. Cancer Epidemiol. Biomark. Prev., 2000, 9, 239-247.
72. MacFarlane, A.J.; Stover, P.J. Factors in gastrointestinal cancers: convergence of genetic, nutritional and inflammatory. Nutr. Rev., 2007, 65, S157-S166.
73. Clemente, A.; Gee, J. M.; Johnson, I. T.; MacKenzie, D. A.; Domoney, C. Pea (Pisum sativum L.) protease inhibitors from the Bowman-Birk class influence the growth of human colorectal adenocarcinoma HT29 cells in vitro. J. Agric. Food Chem., 2005, 53, 8979-8986.
74. Kennedy, A.R.; Billings, P.C.; Wan, X.S.; Newberne, P.M. Effects of Bowman-Birk inhibitor on rat colon carcinogenesis. Nutr. Cancer, 2002, 43, 174-186.
75. St Clair, W.; Billings, P.; Carew, J.; Keller-McGandy, C.; Newberne, P.; Kennedy, A.R. Suppression of dimethylhydrazine-induced carcinogenesis in mice by dietary addition of the Bowman-Birk protease inhibitor. Cancer Res. 1990, 50, 580-586.
76. Yavelow, J.; Collins, M.; Birk, Y.; Troll, W.; Kennedy, A.R. Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress X-ray induced transformation in vitro. Proc. Natl. Acad. Sci. USA, 1985, 82, 5395-5399.
77. Lee, S.L.; Dickson, R.B.; Lin C.Y. Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J. Biol. Chem., 2000, 275, 36720-36725.
78. Darmoul, D.; Gratio, V.; Devaud, H.; Lehy, T.; Laburthe, M. Aberrant expression and activation of the thrombin receptor protease activated receptor-1 induces cell proliferation and motility in human colon cancer cells. Am. J. Pathol., 2003, 162, 1503-1513.
79. Turk, B. Targeting proteases: successes, failures and future prospects. Nat. Rev. Drug Discov. 2006, 5, 785-799.
80. Wu, W.K.K.; Cho, C.H.; Lee, C.W.; Wu, K.; Fan, D.; Yu, J.; Sung, J.J.Y. Proteasome inhibition: a new therapeutic strategy to cancer treatment. Cancer Lett., 2010, 293, 15-22.
81. Adams, J. The proteasome: structure, function and role in the cell. Cancer Treat. Rev., 2003, 29, 3-9.
82. Kisselev, A.F. Joining the army of proteasome inhibitors. Chem. Biol. 2008, 15, 429-431.
83. Chen, Y.W.; Huang, S.C.; Lin-Shiau, S.Y.; Lin, J.K. Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1. Carcinogenesis, 2005, 26, 1296-1305.
84. Billings, P.C.; Brandon, D.L.; Habres, J.M. Internalization of the Bowman-Birk protease inhibitor by intestinal epithelial cells. Eur. J. Cancer, 1991, 27, 903-908.
85. Bhatt, A.S.; Takeuchi, T.; Ylstra, B.; Ginzinger, D.; Albertson, D.; Shuman, M.A.; Craik, C.S. Quantitation of membrane type serine protease 1 (MT-SP1) in transformed and normal cells. Biol. Chem., 2003, 384, 257-266.
86. Long, Y.Q.; Lee, S.L.; Lin, C.Y.; Eneyedy, I.J.; Wang, S.; Li, P.; Dickson, B.R.; Roller, P.P. Synthesis and evaluation of the sunflower derived trypsin inhibitor as a potent inhibitor of the type II transmembrane serine protease, matriptase. Bioorg. Med. Chem. Lett., 2001, 11, 2515-2519.
87. Yamasaki, Y.; Satomi, S.; Murai, N.; Tsuzuki, S.; Fushiki, T. Inhibition of membrane-type serine protease 1/matriptase by natural and synthetic protease inhibitors. J. Nutr. Sci. Vitaminol., 2003, 49, 27-32.
88. Billings, P.C.; Newberne, P.; Kennedy, A.R. Protease inhibitor suppression of colon and anal gland carcinogenesis induced by dimethylhydrazine. Carcinogenesis, 1990, 11, 1083-1086.
89. Ware, H.W.; Wan, S.; Newberne, P.; Kennedy, A.R. Bowman-Birk concentrate reduces colon inflammation in mice with dextran sulphate sodium-induced ulcerative colitis. Digest. Dis. Sci. 1999, 44, 986-990.
90. Sutherland, L.R.; Martin, F.; Greer, S.; Robinson, M.; Greenberger, N.; Saibil, F.; Martin, T.; Sparr, J.; Prokipchuck, E.; Borgen, L. 5-aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis and proctitis. Gastroenterol., 1987, 92, 1894-1898.
91. Shimoda, N.; Fukazawa, N.; Nonomura, K.; Fairchild, R.L. Cathepsin G is required for sustained inflammation and tissue injury after reperfusion of ischemic kidneys. Am. J. Pathol., 2007, 170, 930-940.
92. Annaházi, A.; Gecse, K.; Dabek, M.; Ait-Belgnaoui, A.; Rosztóczy, A.; Róka, R.; Molnár, T.; Theodorou, V.; Wittmann, T.; Bueno, L.; Eutamene, H. Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice. Pain, 2009, 144, 209-217.
93. Yoshida, N.; Isozaki, Y.; Tagaki, T.; Takenaka, S.; Uchikawa, R.; Arizono, N.; Yoshikawa, T.; Okanoue, T. Anti-tryptase therapy in inflammatory bowel disease. Aliment. Pharmacol. Ther., 2006, 24, 249-255.
94. Roka, R.; Rosztoczy, A.; Leveque, M.; Izbeki, F.; Nagy, F.; Molnar, T.; Lonovics, J.; Garcia-Villar, R.; Fioramonti, J.; Wittmann, T.; Bueno, L. A pilot study of fecal serine-protease activity: A pathophysiologic factor in diarrhea-predominant irritable bowel syndrome. Clin. Gastroenterol. Hepatol., 2007, 5, 550-555.
95. Gecse, K.; Roka, R.; Ferrier, L.; Leveque, M.; Eutamene, H.; Cartier, C.; Ait-Belgnaoui, A.; Rosztoczy, A.; Izbeki, F.; Fioramonti, J.; Wittmann, T; Bueno, L. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity. Gut, 2008, 57, 591-599.
96. Hawkins, J.V.; Emmel, E.L.; Feuer, J.J.; Nedelman, M.A.; Harvey, C.J.; Klein, H.J.; Rozmiarek, J.; Lichtenstein, G.R.; Billings, P.C. Protease activity in a hapten-induced model of ulcerative colitis in rats. Dig. Dis. Sci., 1997, 42, 1969-1980.
97. Larionova, N.I.; Gladysheva, I.P.; Tikhonova T.V.; Kazanskaya, N.F. Inhibition of cathepsin G and human granulocyte elastase by multiple forms of Bowman-Birk type soybean inhibitor. Biochem.- Moscow, 1993, 58, 1046-1052.
98. Gladysheva, I.P.; Zamolodchikova, T.S.; Sokolova, E.A.; Larionova, N.I. Interaction between duodenase, a proteinase with dual specificity, and soybean inhibitors of Bowman-Birk and Kunitz type. Biochem. Moscow, 1999, 64, 1244-1249.
99. Ware, J.H.; Wan, X.-S.; Rubin, H.; Schechter, N.M.; Kennedy, A.R. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase. Arch. Biochem. Biophys., 1997, 344, 133-138.
100. McBride, J.D.; Freeman, H.N.; Leatherbarrow, R.J. Identification of chymotrypsin inhibitors from a second-generation template assisted combinatorial peptide library. J. Peptide Sci., 2000, 6, 446-452.
101. Clemente, A.; MacKenzie, D.A.; Jeenes, D.J.; Domoney, C. The effect of variation within inhibitory domains on the activity of pea protease inhibitors from the Bowman-Birk class. Protein Express. Purif., 2004, 36, 106-114.
102. Schechter, I.; Berger, A. On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun., 1967, 27, 157-162.
103. Legowska, A.; Debowski, D.; Lesner, A.; Wysocka, M.; Rolka, K. Introduction of non-natural amino acid residues into the substratespecific P-1 position of trypsin inhibitor SFTI-1 yields potent chymotrypsin and cathepsin G inhibitors. Bioorg. Med. Chem., 2009, 17, 3302-3307.
104. Legowska, A.; Debowski, D.; Lesner, A.; Wysocka, M.; Rolka, K. Selection of peptomeric inhibitors of bovine alpha-chymotrypsin and cathepsin G based on trypsin inhibitor SFTI-1 using a combinatorial chemistry approach. Mol. Divers., 2010, 14, 51-58.
105. Korsinczky, M.L.; Schirra, H.J.; Rosengren, K.J.; West, J.; Condie, B.A.; Otvos, L.; Anderson, M.A.; Craik, D.J. Solution structures by 1H NMR of the novel cyclic trypsin inhibitor SFTI-1 from sunflower seeds and an acyclic permutant. J. Mol. Biol., 2001, 311, 579-591.
106. Austin, J.; Kimura, R.H.; Woo, Y.H.; Camarero, J.A. In vivo biosynthesis of an Ala-scan library based on the cyclic peptide SFTI-1. Amino Acid, 2010, 38, 1313-1322.
107. Wan, X.S.; Lu, L.J.; Anderson, K.E.; War, J.H.; Kennedy, A.R. Urinary excretion of Bowman-Birk inhibitor in humans after soy consumption as determined by a monoclonal antibody-based immunoassay. Cancer Epidemiol. Biomark. Prev., 2000, 9, 741-747.
108. Wan, X.S.; Serota, D.G.; Ware, J.H.; Crowell, J.A.; Kennedy, A.R. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate. Nutr. Cancer, 2002, 43, 167-173.
109. Wan, X.S.; Meyskens, F.L.; Armstrong, W.B.; Taylor, T.H.; Kennedy, A.R. Relationship between protease activity and neu oncogene expression in patients with oral leukoplakia treated with the Bowman-Birk inhibitor. Cancer Epidemiol. Biomark. Prev., 1991, 8, 601-608.
110. Sun, X.Y.; Donald, S.P.; Phang, J.M. Testosterone and prostate specific antigen stimulate generation of reactive oxygen species in prostate cancer cells. Carcinogenesis, 2001, 22, 1775-1780.
111. Dittmann, K.; Virsik-Kopp, P.; Mayer, C.; Rave-Frank, M.; Rodemann, H.P. The radioprotective effect of BBI is associated with the activation of DNA repair-relevant genes. Int. J. Radiat. Biol., 2003, 79, 801-808.
112. Wan, X.S.; Ware, J.H.; Zhang, L.L.; Newberne, P.M.; Evans, S.M.; Clark, L.C.; Kennedy, A.R. Treatment with soybean-derived Bowman-Birk inhibitor increases serum prostate-specific antigen concentration while suppressing growth of human prostate cancer xenografts in nude mice. Prostate, 1999, 41, 243-252.
113. Kennedy, A.R.; Wan, X.S. Effects of the Bowman-Birk inhibitor on growth, invasion and clonogenic survival of human prostate epithelial cells and prostate cancer cells. Prostate, 2002, 50, 125-133.
114. Tang, M.X.; Asamaoto, M.; Ogawa, K.; Naiki-Ito, A.; Sato, S.; Takahashi, S.; Shirai, T. Induction of apoptosis in the LNCaP human prostate carcinoma cell line and prostate adenocarcinomas of SV40T antigen transgenic rats by the Bowman-Birk inhibitor. Pathol. Int. 2009, 59, 790-796.
115. Joanitti, G.A.; Azevedo, R.B.; Freitas, S.M. Apoptosis and lysosome membrane permeabilization induction on breast cancer cells by an anticarcinogenic Bowman-Birk protease inhibitor from Vigna unguiculata seeds. Cancer Lett., 2010, 293, 73-81.
116. Ware, J.H.; Wan, X.S.; Kennedy, A.R. Bowman-Birk inhibitor suppresses production of superoxide anion radicals in differentiated HL-60 cells. Nutr. Cancer, 1999, 33, 174-177.
117. Witschi, H.; Kennedy, A.R. Modulation of lung tumor development in mice with the soybean-derived Bowman-Birk protease inhibitor. Carcinogenesis, 1989, 10, 2275-2277.
118. Chang, J.D.; Li, J.H.; Billings, P.C.; Kennedy, A.R. Effects of protease inhibitors on c-myc expression in normal and transformed C3H-10T1/2 cell lines. Mol. Carcinog., 1990, 3, 226-232.
119. Caggana, M.; Kennedy, A.R. C-fos messenger-RNA levels are reduced in the presence of antipain and Bowman-Birk inhibitor. Carcinogenesis, 1989, 10, 2145-2148.
120. Zhang, L.L.; Wan, X.S.; Donahue, J.J.; Ware, J.H.; Kennedy, A.R. Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells. Nutr. Cancer, 1999, 33, 165-173.
121. Clawson, G.A. Protease inhibitors and carcinogenesis: A review. Cancer Invest., 1996, 14, 597-608.
122. Hsieh, C.C.; Hernandez-Ledesma, B.; Jeong, H.J.; Park, J.H.; de Lumen, B.O. Complementary roles in cancer prevention: protease inhibitor makes the cancer preventive peptide lunasin bioavailable. PLoS ONE, 2010, 5, e8890.
123. Dittmann, K.; Löffler, H.; Bamberg, M.; Rodemann, H.P. Bowman-Birk proteinase inhibitor (BBI) modulates radiosensitivity and radiation-induced differentiation of human fibroblasts in culture. Radiother. Oncol., 1995, 34, 137-143.
124. Dittmann, K.; Toulany, M.; Classen, J.; Heinrich, V.; Milas, L. Selective radioprotection of normal tissues by Bowman-Birk proteinase inhibitor (BBI) in mice. Strahlenther Onkol., 2005, 181, 191-196.
125. Dittmann, K.H.; Gueven, N.; Mayer, C.; Ohneseit, P.; Zell, P.; Begg, A.C.; Rodemann, H.P. The presence of wild-type TP53 is necessary for the radioprotective effect of the Bowman-Birk proteinase inhibitor in normal fibroblasts. Radiat. Res., 1998, 150, 648-655.
126. Dittmann, K.; Mayer, C.; Kehlbach, R.; Rodemann, H.P. The radioprotector Bowman-Birk proteinase inhibitor stimulates DNA repair via epidermal growth factor receptor phosphorylation and nuclear transport. Radiother. Oncol., 2008, 86, 375-382.
127. Gueven, N.; Dittmann, K.; Mayer, C.; Rodemann, H.P. Bowman-Birk protease inhibitor reduces the radiation-induced activation of the EGF receptor and induces tyrosine phosphatase activity. Int. J. Radiat. Biol., 1998, 73, 157-162.
128. Gueven, N.; Dittmann, K.; Mayer, C.; Rodemann, H.P. The radioprotective potential of the Bowman-Birk protease inhibitor is independent of its secondary structure. Cancer Lett., 1998, 125, 77-82.
129. Davis, J.G.; Wan, X.S.; Ware, J.H.; Kennedy, A.R. Dietary supplements reduce the cataractogenic potential of proton and HZEparticle radiation in mice. Radiat. Res., 2010, 173, 353-361.
130. Touil, T.; Ciric, B.; Ventura, E.; Shindler, K.S.; Gran, B.; Tostami, A. Bowman-Birk inhibitor suppresses inflammation and neuronal loss in a mouse model of multiple sclerosis. J. Neurol. Sci., 2008, 271, 191-202.
131. Gran, B.; Tabibzadeh, N.; Martin, A.; Ventura, E.S.; Ware, J.H.; Zhang, G.X.; Parr, J.L.; Kennedy, A.R.; Rostami, A.M. The protease inhibitor, Bowman-Birk inhibitor, suppresses experimental autoimmune encephalomyelitis: a potential oral therapy for multiple sclerosis. Mult. Scler., 2006, 12, 688-697.
132. Morris, C.A.; Morris, L.D.; Kennedy, A.R.; Sweeney, H.L. Attenuation of skeletal muscle atrophy via protease inhibition. J. Appl. Physiol., 2005, 99, 1719-1727.
133. Arbogast, S.; Smith, J.; Matuszczak, Y.; Hardin, B.J.; Moylan, J.S.; Smith, J.D.; Ware, J.; Kennedy, A.R.; Reid, M.B. Bowman-Birk inhibitor concentrate prevents atrophy, weakness, and oxidative stress in soleus muscle of hindlimb-unloaded mice. J. Appl. Physiol., 2007, 102, 956-964.
134. Schmutz, J.; Cannon, S.B.; Schlueter, J.; Ma, J.; Mitros, T.; Nelson, W.; Hyten, D.L.; Song, Q.J.; Thelen, J.J.; Cheng, J.L.; Xu, D.; Hellsten, U.; May, G.D.; Yu, Y.S.; Sakurai, T.; Umezawa, T.; Bhattacharyya, M.K.; Sandhu, D.; Valliyodan, B.; Lindquist, E.; Peto, M.; Grant, D.; Shu, S.Q.; Goodstein, D.; Barry, K.; Futrell-Griggs, M.; Abernathy, B.; Du, J.C.; Tian, Z.X.; Zhu, L.C.; Gill, N.; Joshi, T.; Libault, M.; Sethuraman, A.; Zhang, X.C.; Shinozaki, K.; Nguyen, H.T.; Wing, R.A., Cregan, P.; Specht, J.; Grimwood, J.; Rokhsar, D.; Stacey, G.; Shoemaker, R.C.; Jackson, S.A. Genome sequence of the palaeopolyploid soybean. Nature, 2010, 463, 178-183.
135. Goulet, C.; Benchabane, M.; Anguenot, R.; Brunelle, F.; Khalf, M.; Michaud, D. A companion protease inhibitor for the protection of cytosol-targeted recombinant proteins in plants. Plant Biotech. J., 2010, 8, 142-154.
136. Komarnytsky, S.; Borisjuk, N.; Yakoby, N.; Garvey, A.; Raskin, I. Cosecretion of protease inhibitor stabilizes antibodies produced by plant roots. Plant Physiol., 2006, 141, 1185-1193.
137. Dalmais, M.; Schmidt, J.; Le Signor, C; Moussy, F; Burstin, J; Savois, V.; Aubert, G.; Brunaud, V.; de Oliveira, Y.; Guichard, C; Thompson, R; Bendahmane, A. UTILLdb, a Pisum sativum in silico forward and reverse genetics tool. Genome Biol., 2008, 9, 1-12
138. Hofer, J.; Turner, L.; Moreau, C.; Ambrose, M.; Isaac, P.; Butcher, S.; Weller, J.; Dupin, A.; Dalmais, M.; Le Signor, C.; Bendahmane, A.; Ellis, N. Tendril-less regulates tendril formation in pea leaves. Plant Cell, 2009, 21, 420-428.
139. Le Signor, C.; Savois, V.; Aubert, G.; Verdier, J.; Nicolas, M.; Pagny, G.; Moussy, F.; Sanchez, M.; Baker, D.; Clarke, J.; Thompson, R. Optimizing TILLING populations for reverse genetics in Medicago truncatula. Plant Biotech. J., 2009, 7, 430-441.
140. Domoney, C. Inhibitors of legume seeds. In: Seed Proteins. Shewry, P.R.; Casey R., Eds. Kluwer Academic Publishers, The Netherlands; 1999; pp. 635-655.
141. Craik, D.J.; Daly, N.L.; Bond, T.; Waine, C. Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. J. Mol. Biol., 1999, 294, 1327-1336.
142. McBride, J.D.; Watson, E.M.; Brauer, A.B.E.; Jaulent, A.M.; Leatherbarrow, R.J. Peptide mimics of the Bowman-Birk inhibitor reactive site loop. Biopolymers, 2002, 66, 79-92.
143. Thongyoo, P.; Jaulent, A.M.; Tate, E.W.; Leatherbarrow, R.J. Immobilized protease-assisted synthesis of engineered cysteineknot microproteins. Chem. Biochem., 2007, 8, 1107-1109.
144. Higgins, T.J.V.; Chandler, P.M.; Randall, P.J.; Spencer, D.; Beach, L.R.; Blagrove, R.J.; Kortt, A.A.; Inglis, A.S. Gene structure, protein structure and regulation of the synthesis of a sulphur-rich protein in pea seeds. J. Biol. Chem., 1986, 261, 11124-11130.
145. Garcia-Olmedo, F.; Salcedo, G.; Sanchez-Monge, R.; Gomez, L.; Royo, J.; Carbonero, P. Plant proteinaceous inhibitors of proteinases and a-amylases. Oxford Surv. Plant Mol. Cell Biol., 1987, 4, 275-334.
146. Gelly, J.C.; Gracy, J.; Kaas, Q.; Le-Nguyen, D.; Heitz, A.; Chiche, L. The KNOTTIN website and database: a new information system dedicated to the knottin scaffold. Nucleic Acid Res., 2004, 32, D156-D159.
147. Louis, S.; Delobel, B.; Gressent, F.; Duport, G.; Diol, O.; Rahioui, I.; Charles, H.; Rahbé, Y. Broad screening of the legume family for variability in seed insecticidal activities and for the occurrence of the A1b-like knottin peptide entomotoxins. Phytochem., 2007, 68, 521-535.
148. Shewry, P.R.; Lucas, J.A. Plant proteins that confer resistance to pest and patghogens. Adv. Bot. Res., 1997, 26, 135-192.
149. Gressent, F.; Rahioui, I.; Rahbé, Y. Characterisation of a high affinity binding site for the pea albumin 1b (PA1b) entomotoxin in the weevil Sitophilus. Eur. J. Biochem., 2003, 270, 2429-2435.
150. Louis, S.; Delobel, B.; Gressent, F.; Rahioui, I.; Quillien, L.; Vallier, A.; Rahbé, Y. Molecular and biological screening for insecttoxic seed albumins from four legume species. Plant Sci., 2004, 167, 705-714.
151. Thomma, B.P.H.G.; Cammeu, B.P.A.; Thevissen, K. Plant defensins. Planta, 2002, 216, 193-202.
152. Liu, Y.J.; Cheng, C.S.; Lai, S.M.; Hsu, M.P.; Chen, C.S.; Lyu, P.C. Solution structure of the plant defensin VrD1 from mung bean and its possible role in insecticidal activity against bruchids. Proteins, 2006, 63, 777-786.
153. Almeida, M.S.; Cabral, K.M.; Zingali, R.B.; Kurtenbach, E. Characterization of two novel defense peptides from pea (Pisum sativum) seeds. Arch. Biochem. Biophys., 2000, 378, 278-286.
154. Almeida, M.S.; Cabral, K.M.; Kurtenbach, E.; Almeida, F.C.; Valente, A.P. Solution structure of Pisum sativum defensin 1 by high resolution NMR: Plant defensins, identical backbone with different mechanisms of action. J. Mol. Biol., 2002, 315, 749-757.
155. Chiang, C.C.; Hadwiger, L.A. The Fusarium solani induced expression of a pea gene family encoding high cysteine content proteins. Mol. Plant Microbe Interact., 1991, 4, 324-331.
156. Broekaert, W.F.; Terras, F.R.G.; Cammue, B.P.A.; Osborn, R.W. Plant defensins: novel antimicrobial peptides as components of the host defense system. Plant Physiol., 1995, 108, 1353-1358.
157. Broekaert, W.F.; Cammune, B.P.A.; De Bole, M.F.C.; Thevissen, K.; De Samblanx, G.W.; Osborn, R.W. Antimicrobial peptides from plants. Crit. Rev. Plant Sci., 1997, 16, 297-323.
158. Osborn, R.W.; De Samblanx, G.W.; Thevissen, K.; Goderis, I.; Torrekens, S.; Van Leuven, F.; Attenborough, S.; Rees, S.B.; Broekaert, W.F. Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae. FEBS Lett., 1995, 368, 257-262.
159. Kolmar, H. Alternative binding proteins: Biological activity and therapeutic potential of cystine-knot miniproteins. FEBS J., 2008, 275, 2684-2690.
160. Silverstein, K.A.T.; Moskal, W.A.; Wu, H.C.; Underwood, B.A.; Graham, M.A.; Town, C.D.; Van den Bosch, K.A. Small cysteine-rich peptides resembling antimicrobial peptides have been under-predicted in plants. Plant J., 2007, 51, 262-280.
161. Selitrennikoff, C.P. Antifungal proteins. Appl. Environ. Microbiol., 2001, 67, 2883-2894.
162. Wong, J.H.; Ng, T.B. Sesquin, a potent defensin-like antimicrobial peptide from ground beans with inhibitory activities toward tumor cells and HIV-1 reverse transcriptase. Peptide, 2005, 26, 1120-1126.
163. Galvez, A.F.; Chen, N.; Macasieb, J.; de Lumen, B.O. Chemopreventive property of a soybean peptide (lunasin) that binds to deacetylated histones and inhibits acetylation. Cancer Res., 2001, 61, 7473-7478.
164. Scarpi, D.; McBride, J.D.; Leatherbarrow, R.J. Inhibition of human β-tryptase by Bowman-Birk inhibitor derived peptides. J. Pept. Sci., 2002, 59, 90-93.
165. McBride, J.D.; Freeman, H.N.M.; Leatherbarrow, R.J. Selection of human elastase inhibitors from a conformationally-constrained combinatorial peptide library. Eur. J. Biochem., 1999, 266, 403-412.
166. Fernandes, A.O.; Banerji, A.P. Inhibition of benzopyrene-induced forestomach tumors by field bean protease inhibitor (s). Carcinogenesis, 1995, 16, 1843-1846.
167. Barbosa, J.A.R.G.; Silva, L.P.; Teles, R.C.L.; Esteves, G.F.; Azecevo, R.B.; Ventura, M.M.; de Freitas, S.M. Crystal structure of the Bowman-Birk inhibitor from Vigna unguiculata seeds in complex with β-trypsin at 1.55 Å resolution and its structural properties in association with proteinases. Biophys. J., 2007, 92, 1638-1650.
168. Berman, H.M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T.N.; Weissing, H.; Shindyalov, I.N.; Bourne, P.E. The Protein Data Bank. Nucleic Acids Res., 2000, 28, 235-242.